RBC Capital analyst Ben Hendrix maintains Select Medical Hldgs (NYSE:SEM) with a Outperform and lowers the price target from $36 to $32.
RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.